pharmaceutical investing MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) in Glioblastoma
pharmaceutical investing Supernus Announces First Quarter 2018 Financial Results and Record Quarterly Revenue
pharmaceutical investing Opiant Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results and Provides Corporate Update
Arch Biopartners Completes Pre-IND Meeting with U.S. FDA on LSALT Peptide for Preventing Acute Kidney Injury in Cardiac Surgery Patients
pharmaceutical investing Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease
pharmaceutical investing Nabriva Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
pharmaceutical investing Cellular Biomedicine Group Reports First Quarter 2018 Financial Results and Highlights Operational Progress
cannabis investing Koios Beverage Corp. Announces Final Bulletin and Trading Date in Connection with Fundamental Change Transaction
medical device investing Medtronic Announces FDA Approval of Infuse Bone Graft in New Spine Surgery Indications Using PEEK Interbody Implants
pharmaceutical investing Ultragenyx and Kyowa Kirin Announce Crysvita Now Launched in the U.S. for the Treatment of X–linked Hypophosphatemia
SAGA Metals Announces Additional Assay Results from Drilling at Trapper North, Confirming High-Grade Mineralization at Radar Critical Minerals Project in Labrador
Providence Gold Mines Inc. Announces Final Approval of Reviewable Transaction and The La Dama de Oro Gold Property NI43 101 Report
